Quetiapine Fumarate XR Tablets

SOL #: SPE2D223D0012Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Hauppauge, NY

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Sep 7, 2023
2
Last Updated
Sep 26, 2024

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Modification SPE2D223D0012 P00004 to exercise Option Year 1.

People

Points of Contact

Nancy FernandezPRIMARY
Jason WraySECONDARY

Files

Files

Download
Download
Download
Download

Versions

Version 4Viewing
Award Notice
Posted: Sep 26, 2024
Version 3
Award Notice
Posted: Sep 19, 2023
View
Version 2
Award Notice
Posted: Sep 8, 2023
View
Version 1
Award Notice
Posted: Sep 7, 2023
View
Quetiapine Fumarate XR Tablets | GovScope